FDA
Rasagiline Mesylate
The FDA lists this product in 26 strengths and forms.
Composition
- Active ingredients
- RASAGILINE MESYLATE EQ 0.5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RASAGILINE MESYLATE EQ 1MG BASE · TabletANDA201823-002 · Discontinued
- RASAGILINE MESYLATE EQ 0.5MG BASE · TabletANDA201823-001 · Discontinued
- RASAGILINE MESYLATE EQ 1MG BASE · TabletANDA201892-002 · Prescription
- RASAGILINE MESYLATE EQ 0.5MG BASE · TabletANDA201892-001 · Prescription
- RASAGILINE MESYLATE EQ 0.5MG BASE · TabletANDA201899-001 · Tentative approval
- RASAGILINE MESYLATE EQ 1MG BASE · TabletANDA201899-002 · Tentative approval
- RASAGILINE MESYLATE EQ 0.5MG BASE · TabletANDA207004-001 · Prescription
- RASAGILINE MESYLATE EQ 1MG BASE · TabletANDA207004-002 · Prescription
- RASAGILINE MESYLATE EQ 0.5MG BASE · TabletANDA201942-001 · Prescription
- RASAGILINE MESYLATE EQ 1MG BASE · TabletANDA201942-002 · Prescription
- RASAGILINE MESYLATE EQ 0.5MG BASE · TabletANDA201950-001 · Discontinued
At a glance
- Brand name
- Rasagiline Mesylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Aurobindo Pharma USA
- Status
- Prescription
- FDA approval
- 15 May 2017
- Application
- ANDA201971-001